CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.

Glycoside Hydrolase Family 66

From CAZypedia
Revision as of 07:59, 7 October 2013 by Harry Brumer (talk | contribs) (added some internal and external links)
Jump to navigation Jump to search
Approve icon-50px.png

This page has been approved by the Responsible Curator as essentially complete. CAZypedia is a living document, so further improvement of this page is still possible. If you would like to suggest an addition or correction, please contact the page's Responsible Curator directly by e-mail.


Glycoside Hydrolase Family GH66
Clan none, (β/α)8
Mechanism retaining
Active site residues known
CAZy DB link
https://www.cazy.org/GH66.html


Substrate specificities

Glycoside hydrolases of GH66 contains endo-acting dextranase (Dex; EC 3.2.1.11) and cycloisomaltooligosaccharide glucanotransferase (CITase; EC 2.4.1.248). Dexs hydrolyze α-1,6 linkage of dextran and produce isomaltooligosaccharides (IGs) of varying length. Dexs from oral streptococci have been analyzed since 1970s [1, 2, 3]. Dexs are classified into GH49 and GH66. In contrast to inverting GH49 enzymes, GH66 enzymes show retaining enzymatic properties. CITases catalyze intramolecular transglucosylation to produce cycloisomaltooligosaccharides (CIs; cyclodextrans) with degree of polymerization of 7-17 [4]. CITases produce CIs from IG4 and larger IGs [5]. CITase from Bacillus circulans T-3040 (CITase-T3040) produced CI-8 predominantly from dextran 40, whereas the major product of CITase from Paenibacillus sp. 598K (CITase-598K) was CI-7 [5, 6]. CITases contain a CITase-specific insertion (about 90 residues) inside the catalytic domain. The insertion region is a family 35 carbohydrate-binding module (CBM35) domain [6]. Some Dexs displaying strong dextranolytic activity with low cyclization activity have been discovered [7, 8]. The GH66 enzymes are classified into the following three types: (Type I) Dexs, (Type II) Dexs with low CITase activity, and (Type III) CITases [7, 8].

Kinetics and Mechanism

GH66 enzymes are retaining enzymes, as first shown by structural [9] and chemical rescue studies [7]. The kcat and KM values of Dex from Bacteroides thetaiotaomicron VPI-5482 (BtDex) toward dextran T2000 were determined to be 86.7 s-1 and 0.029 mM, respectively [8]. Both CITase-T3040 and CITase-598K showed the same KM value for dextran 40 (0.18 mM) [5]. The kcat values of CITase-T3040 and CITase-598K against dextran 40 were 3.2 s-1 and 5.8 s-1, respectively [5].

Catalytic Residues

To date, catalytic residues of four GH66 enzymes have been identified by mutational and structural studies [5, 7, 9, 10]. The catalyic nucleophile is aspartic acid and the catalyic acid/base is glutamic acid. Asp385 and Glu453 are nucleophile and acid/base catalyst, respectively, in Dex from Streptococcus mutans (SmDex) [9, 10], Asp340 and Glu412 in Dex from Paenibacillus sp. (PsDex) [7], Asp270 and Glu342 in CITase-T3040 [5], and Asp269 and Glu341 in CITase-598K [5].

Three-dimensional structures

The crystal structures of truncated mutant of SmDex (lacking the N-terminal 99 and C-terminal 118 residues) have been reported as the first three-dimensional structure of GH66 enzymes [9, 11]. Three structures, ligand free (PDB ID 3vmn), in complex with IG3 (PDB ID 3vmo), and in complex with 4’,5’-epoxypentyl-α-D-glucopyranoside (PDB ID 3vmp), have been determined [9]. The catalytic domain of the enzyme is a (β/α)8-barrel fold, accompanied by N-terminal immunoglobulin-like β-sandwich fold and C-terminal β-sandwich structure containing two Greek key motifs. These three domains are the common structural components in GH66 enzymes.

Family Firsts

First stereochemistry determination
CITase-T3040 using 1H-NMR, 13C-NMR, and IR spectra [12].
First catalytic nucleophile identification
SmDex and PsDex by structural study [9] and chemical rescue approach [7], respectively.
First general acid/base residue identification
SmDex and PsDex by structural study [9] and chemical rescue approach [7], respectively.
First 3-D structure
Truncated mutant of SmDex [9] .

References

  1. Staat RH and Schachtele CF. (1974). Evaluation of dextranase production by the cariogenic bacterium Streptococcus mutans. Infect Immun. 1974;9(2):467-9. DOI:10.1128/iai.9.2.467-469.1974 | PubMed ID:4816468 [Staat1974]
  2. Hamada S, Mizuno J, Murayama Y, Ooshima Y, and Masuda N. (1975). Effect of dextranase on the extracellular polysaccharide synthesis of Streptococcus mutans; chemical and scanning electron microscopy studies. Infect Immun. 1975;12(6):1415-25. DOI:10.1128/iai.12.6.1415-1425.1975 | PubMed ID:1205620 [Hamada1975]
  3. Ellis DW and Miller CH. (1977). Extracellular dextran hydrolase from Streptococcus mutans strain 6715. J Dent Res. 1977;56(1):57-69. DOI:10.1177/00220345770560011301 | PubMed ID:14177 [Ellis1977]
  4. Funane K, Terasawa K, Mizuno Y, Ono H, Gibu S, Tokashiki T, Kawabata Y, Kim YM, Kimura A, and Kobayashi M. (2008). Isolation of Bacillus and Paenibacillus bacterial strains that produce large molecules of cyclic isomaltooligosaccharides. Biosci Biotechnol Biochem. 2008;72(12):3277-80. DOI:10.1271/bbb.80384 | PubMed ID:19060390 [Funane2008]
  5. Suzuki R, Terasawa K, Kimura K, Fujimoto Z, Momma M, Kobayashi M, Kimura A, and Funane K. (2012). Biochemical characterization of a novel cycloisomaltooligosaccharide glucanotransferase from Paenibacillus sp. 598K. Biochim Biophys Acta. 2012;1824(7):919-24. DOI:10.1016/j.bbapap.2012.04.001 | PubMed ID:22542750 [SuzukiR2012]
  6. Funane K, Kawabata Y, Suzuki R, Kim YM, Kang HK, Suzuki N, Fujimoto Z, Kimura A, and Kobayashi M. (2011). Deletion analysis of regions at the C-terminal part of cycloisomaltooligosaccharide glucanotransferase from Bacillus circulans T-3040. Biochim Biophys Acta. 2011;1814(3):428-34. DOI:10.1016/j.bbapap.2010.12.009 | PubMed ID:21193067 [Funane2011]
  7. Kim YM, Kiso Y, Muraki T, Kang MS, Nakai H, Saburi W, Lang W, Kang HK, Okuyama M, Mori H, Suzuki R, Funane K, Suzuki N, Momma M, Fujimoto Z, Oguma T, Kobayashi M, Kim D, and Kimura A. (2012). Novel dextranase catalyzing cycloisomaltooligosaccharide formation and identification of catalytic amino acids and their functions using chemical rescue approach. J Biol Chem. 2012;287(24):19927-35. DOI:10.1074/jbc.M111.339036 | PubMed ID:22461618 [Kim2012A]
  8. Kim YM, Yamamoto E, Kang MS, Nakai H, Saburi W, Okuyama M, Mori H, Funane K, Momma M, Fujimoto Z, Kobayashi M, Kim D, and Kimura A. (2012). Bacteroides thetaiotaomicron VPI-5482 glycoside hydrolase family 66 homolog catalyzes dextranolytic and cyclization reactions. FEBS J. 2012;279(17):3185-91. DOI:10.1111/j.1742-4658.2012.08698.x | PubMed ID:22776355 [Kim2012B]
  9. Suzuki N, Kim YM, Fujimoto Z, Momma M, Okuyama M, Mori H, Funane K, and Kimura A. (2012). Structural elucidation of dextran degradation mechanism by streptococcus mutans dextranase belonging to glycoside hydrolase family 66. J Biol Chem. 2012;287(24):19916-26. DOI:10.1074/jbc.M112.342444 | PubMed ID:22337884 [Nsuzu2012]
  10. Igarashi T, Morisaki H, Yamamoto A, and Goto N. (2002). An essential amino acid residue for catalytic activity of the dextranase of Streptococcus mutans. Oral Microbiol Immunol. 2002;17(3):193-6. DOI:10.1034/j.1399-302x.2002.170310.x | PubMed ID:12030973 [Igarashi2002]
  11. Suzuki N, Kim YM, Fujimoto Z, Momma M, Kang HK, Funane K, Okuyama M, Mori H, and Kimura A. (2011). Crystallization and preliminary crystallographic analysis of dextranase from Streptococcus mutans. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011;67(Pt 12):1542-4. DOI:10.1107/S1744309111038425 | PubMed ID:22139161 [Nsuzu2011]
  12. Oguma T, Horiuchi T, and Kobayashi M. Novel Cyclic Dextrins, Cycloisomaltooligosaccharides, from Bacillus sp. T-3040 Culture. Biosci Biotechnol Biochem. 1993 57(7):1225-1227. DOI:10.1271/bbb.57.1225

    [Oguma1993]

All Medline abstracts: PubMed